4-Chloroquinazoline - CAS 5190-68-1
Catalog: |
BB027647 |
Product Name: |
4-Chloroquinazoline |
CAS: |
5190-68-1 |
Synonyms: |
4-chloroquinazoline; 4-chloroquinazoline |
IUPAC Name: | 4-chloroquinazoline |
Description: | 4-Chloroquinazoline can be used to prepare agricultural fungicides. |
Molecular Weight: | 164.59 |
Molecular Formula: | C8H5ClN2 |
Canonical SMILES: | C1=CC=C2C(=C1)C(=NC=N2)Cl |
InChI: | InChI=1S/C8H5ClN2/c9-8-6-3-1-2-4-7(6)10-5-11-8/h1-5H |
InChI Key: | GVRRXASZZAKBMN-UHFFFAOYSA-N |
Boiling Point: | 281 °C at 760 mmHg |
Density: | 1.349 g/cm3 |
MDL: | MFCD00228682 |
LogP: | 2.28320 |
GHS Hazard Statement: | H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P310, P302+P352, P304+P340, P305+P351+P338, P310, P312, P321, P330, P332+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-113200927-A | Synthesis method of N- (3-ethynylphenyl) -quinazoline-4-amine | 20210430 |
CN-113004210-A | Quinazoline-4-selenium salt compound, preparation method and biological activity | 20210329 |
CN-113004211-A | Quinazoline-4-selenoether derivative, preparation method and biological activity | 20210329 |
CN-112457260-A | N-heterocyclic aryl quinazoline-4-amine compound and preparation method thereof | 20201208 |
CN-112390781-A | Diaryl substituted 1, 1-ethylene compound, preparation method and application | 20201118 |
PMID | Publication Date | Title | Journal |
22891752 | 20120913 | Design, synthesis, and pharmacological evaluation of N-acylhydrazones and novel conformationally constrained compounds as selective and potent orally active phosphodiesterase-4 inhibitors | Journal of medicinal chemistry |
18991714 | 20080101 | Imaging of EGFR and EGFR tyrosine kinase overexpression in tumors by nuclear medicine modalities | Current pharmaceutical design |
17962758 | 20060410 | Microwave assisted synthesis of N-arylheterocyclic substituted-4-aminoquinazoline derivatives | Molecules (Basel, Switzerland) |
Complexity: | 140 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 164.0141259 |
Formal Charge: | 0 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 164.0141259 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 25.8 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.9 |
-
Catalog: BB030086
(1-Bromoethyl)benzene
Detail
-
Catalog: BB017138
(1-Bromo-3-chloropropyl)benzene
Detail
-
Catalog: BB035854
(1-Bromocyclopropyl)benzene
Detail
-
Catalog: BB044292
(+)-(8,8-Dichlorocamphorylsulfonyl)oxaziridine
Detail
-
Catalog: BB054256
((2S,4R)-2-((1H-1,2,4-Triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methanol
Detail
-
Catalog: BB025409
(1-Bromo-2,2,2-trifluoroethyl)benzene
Detail
-
Catalog: BB045655
((5-[(4-Chloro-3-methyl-1H-pyrazol-1-yl)methyl]-4-ethyl-4H-1,2,4-triazol-3-yl)thio)acetic acid
Detail
-
Catalog: BB044157
(+)-2,10-(3,3-dichlorocamphorsultam)
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Halides
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS